Skip to main content
Offering
Offering
Integrated Biologics
Integrated Biologics
Expression Technologies
Expression Technologies
GS Xceed® Gene Expression System
GS piggyBac® Transposon Technology
GS Effex® Cell Line
GS Discovery® Transient Expression
bYlok® Bispecific Pairing Technology
XS Technologies® Platform
Technical Support
Early Derisking and Optimization
Early Derisking and Optimization
Developability Assessment
Manufacturability Assessment
Biologics Formulatability
Immunogenicity / Immunotoxicity Assessment
Early Protein Expression Services
Integrated DNA-to-IND Programs
Integrated DNA-to-IND Programs
mAbs DNA-to-IND Program
Bispecifics DNA-to-IND Program
Fabs and Fc-Fusion Proteins DNA-to-IND Programs
Scaffolds and other Recombinant Proteins
Development Services
Development Services
Biologics Process Development
Biologics Analytical Development
Formulation and Primary Packaging Development
Manufacturing
Manufacturing
Mammalian Drug Substance Manufacturing
Drug Product Manufacture
OptiALTO® Intensified Fed-Batch Platform
Mammalian Biopharmaceutical Services
Mammalian Biopharmaceutical Services
Cell Line Development
Tailored License Application Program
Process Development
Drug Product Services
Biologics Regulatory Affairs
Knowledge Center
Advanced Synthesis
Advanced Synthesis
Small Molecules
Small Molecules
Drug Substance/API Services
Drug Substance/API Services
Lonza Design2Optimize® Services
Early Phase Small Molecule Development Services
API Support for Early Phase Development
AI-Enabled Route Scouting Service
Solid Form Drug Services
PBPK Modeling Services
High-Throughput Experimentation Service
Pharmaceutical Method Development
Commercial API Manufacturing Services
Highly Potent API Technologies
Highly Potent API Technologies
HPAPI Handling and Development
HPAPI Manufacturing | Low & High Potency
Bioavailability Enhancement
Bioavailability Enhancement
Amorphous Solid Dispersion Technology
Spray-Dried Dispersion Technology
Hot Melt Extrusion
Drug Product
Drug Product
Clinical Trial Material Manufacture, Supply
Formulation and Development
Design and Preformulation Development
Drug Development Workflow & Pharmaceutical Process Optimization
Inhalation Formulation Development
Integrated Offerings
Regulatory Affairs CMC Services
Regulatory Affairs CMC Services
CMC Development Services | CMC Regulatory Submissions
Bioconjugation Services
Bioconjugation Services
Early Development Bioconjugate Services | ADCs
ADC Drug Substance Manufacturing
Pharmaceutical, ADC Analytical Services
Targeting Agent and Carrier Protein
ADC Process Development
Ibex® Design ADC, DNA-to-IND Program
ADC Clinical and Commercial Manufacturing
ADC Payload Product Development
ADC Technologies Platform
Knowledge Center
Specialized Modalities
Specialized Modalities
Cell & Gene
Cell & Gene
Process Development
cGMP Manufacturing
Allogeneic
Autologous
Viral Vectors
Exosomes
Microbial
Microbial
Microbial Strain Development
Process Development
Drug Substance Manufacturing
Analytical Development
mRNA/LNP
mRNA/LNP
Process Development
Analytical Services
mRNA Manufacturing
Lipid Nanoparticles Encapsulation
Bioscience Products
Knowledge Center
Knowledge Center
Company
Company
About Us
About Us
Our One Lonza Strategy
Our Leadership
Our Leadership
Executive Committee
Board of Directors
Board Committees
Our History
Our Locations
News and Media
News and Media
News Releases
Images and Videos
Logo Guidelines
Blog
A View On - Lonza Podcast
Journalist Inquiries
Investor Relations
Investor Relations
Shareholder and Bondholder Information
Shareholder and Bondholder Information
Consensus and Analysts
Bond Investors and Credit Information
Investor FAQ
Share Buyback
Agenda and Events
Reporting and Presentations
Corporate Governance
Ethics and Compliance
Investor Inquiries and Feedback
Sustainability
Sustainability
Environment
People and Society
Compliance and Integrity
Responsible Sourcing
Global Quality
Careers
Careers
Welcome to Lonza
Life at Lonza
Employee Benefits
Early Career Opportunities
Inclusion, Diversity and Belonging
Join Our Talent Community
Contact
Search
Cancel
Group Lead, Early Phase Clinical Manufacturing
United States, Bend (Oregon)
Reference: R78229
Apply
Cookie Settings
|
Terms and Conditions
|
Legal Disclaimer
|
Privacy Policy
|
Accessibility
|
Sitemap